NCT07063524 Transcutaneous Electrical Stimulation and Controlled Heat in People With and Without Diabetes
| NCT ID | NCT07063524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Western Michigan University |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-05-10 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-05-10 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators would like to see if the combination of TENS and controlled heat in a boot increases blood flow to the foot more than baseline or heat alone in people with and without diabetes. This may help people with diabetes and a diabetic wound that will not heal.
Eligibility Criteria
Inclusion Criteria: * Male or Female aged between 45-75 years old * Clinical diagnosis of Type I or Type II diabetes * Controlled diabetes mellitus (HbA1c ≤ 7%) Exclusion Criteria: * Pregnancy * Current smoker * Diagnosed neuropathy * Uncontrolled hypertension (HTN) * Allergy to tape or electrodes * Diagnosis of dementia * History of knee joint replacement * Significant joint pain (e.g., back, hip, or ankle) that may limit the ability to wear a boot for 60 minutes * Contraindications to TENS, including: * Presence of pacemakers * Dermatological conditions * Abnormal sensation in the knees * Severe medical or neurological conditions, including: * Chronic obstructive pulmonary disease * Cardiovascular disease * Arteriosclerosis obliterans * Cerebrovascular accident * Lumbar disc disorders (e.g., herniation) * Rheumatoid arthritis * Fear of electrical stimulation
Contact & Investigator
Massood Atashbar, PhD
PRINCIPAL INVESTIGATOR
Western Michigan University
Frequently Asked Questions
Who can join the NCT07063524 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 75 Years, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07063524 currently recruiting?
Yes, NCT07063524 is actively recruiting participants. Contact the research team at massood.atashbar@wmich.edu for enrollment information.
Where is the NCT07063524 trial being conducted?
This trial is being conducted at Kalamazoo, United States.
Who is sponsoring the NCT07063524 clinical trial?
NCT07063524 is sponsored by Western Michigan University. The principal investigator is Massood Atashbar, PhD at Western Michigan University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.